doi: 10.1016/0049-3848(80)90170-x.
Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats
- PMID: 7404505
- DOI: 10.1016/0049-3848(80)90170-x
Item in Clipboard
Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats
Thromb Res.
1980 Apr.
No abstract available
Similar articles
-
Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.Thromb Res. 1980 Mar 1;17(5):663-71. doi: 10.1016/0049-3848(80)90369-2. Thromb Res. 1980. PMID: 7385100 No abstract available.
-
Experimental model of venous thrombosis in rats and effect of some agents.Thromb Res. 1980 Apr 1-15;18(1-2):189-203. doi: 10.1016/0049-3848(80)90183-8. Thromb Res. 1980. PMID: 7404498 No abstract available.
-
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.J Lab Clin Med. 1982 Mar;99(3):428-41. J Lab Clin Med. 1982. PMID: 6460069
-
Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.Thromb Res Suppl. 1983;4:119-28. doi: 10.1016/0049-3848(83)90367-5. Thromb Res Suppl. 1983. PMID: 6356462 Review.
-
Antiplatelet drugs in the management of patients with thrombotic disorders.Semin Thromb Hemost. 1986 Apr;12(2):134-55. doi: 10.1055/s-2007-1003545. Semin Thromb Hemost. 1986. PMID: 3016905 Review. No abstract available.
Cited by
-
Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans.Ann Med. 2023 Dec;55(1):2218105. doi: 10.1080/07853890.2023.2218105. Ann Med. 2023. PMID: 37318081 Free PMC article.
-
Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review.Iran J Basic Med Sci. 2019 Mar;22(3):215-224. doi: 10.22038/ijbms.2019.31119.7513. Iran J Basic Med Sci. 2019. PMID: 31156780 Free PMC article. Review.
-
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003. Drugs. 1987. PMID: 3304967 Review.
-
Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia.J Am Heart Assoc. 2016 Apr 6;5(4):e002889. doi: 10.1161/JAHA.115.002889. J Am Heart Assoc. 2016. PMID: 27053057 Free PMC article.
-
Smoking and the Pathophysiology of Peripheral Artery Disease.Front Cardiovasc Med. 2021 Aug 27;8:704106. doi: 10.3389/fcvm.2021.704106. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34513948 Free PMC article. Review.